Wire · opportunities
Radical Numerics Uses AI-Designed Bacteriophage Virus in First Patient Treatment ...
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 24 October 2026 · Fusion42 review
US biotech startup Radical Numerics, with FDA approval, has administered an AI-designed bacteriophage virus to a patient with a severe antibiotic-resistant bacterial infection, marking the first such treatment using a virus not found in nature. While lab tests show the new bacteriophage can infect and kill the bacteria, clinical efficacy and safety details remain undisclosed and unpeer-reviewed.
This Wire brief sits within Fusion42's coverage of Biotech, and 2 sources have reported it between 22 Oct 2026 and 26 Oct 2026.
◆ ◆ The Wire takeaway
AI-designed therapies just passed a major regulatory gate with FDA approval for human treatment. You in biotech should now seek opportunities to build platforms that design targeted biological treatments faster than traditional methods.
◆ Coverage
2 sources · first reported 22 Oct 2026 · latest 26 Oct 2026
◆ Related on Wire
◆ Topics